Effect of Combined Therapy of Atorvastatin with Milk Thistle Extract on the Functional State of the Liver in Patients with CHD

  • Buvamukhamedova Nasiba Tokhirovna Assistant of Department of Faculty and Hospital Therapy №2, Nephrology and Hemodialysis
  • Zhabbarov Ozimbay Otakhanovich Associate Professor, Department of Faculty and Hospital Therapy №2, Nephrology and Hemodialysis
  • Mirzayeva Gulchekhra Fayzullaevna Assistant of Department of Faculty and Hospital Therapy №2, Nephrology and Hemodialysis
Keywords: CHD, statins, milk thistle extract, liver, ALT, AST

Abstract

Coronary heart disease (CHD) remains the leading cause of death in industrialized countries and with a growing trend in developing countries. The most significant risk factor is hypercholesterolemia. While the most effective drug is statins. Statin therapy is usually well tolerated, but side effects may occur, including elevated liver enzymes, aminotransferases. In this regard, the appointment of statins, together with hepatoprotective drugs, such as: milk thistle extract reduces the side effects of lipid-lowering therapy in patients with CHD.

References

1. Knuuti J., Wijns W., Saraste A., Capodanno D., Barbato E., Funck- Brentano C., et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. ehz425. doi: 10.1093/eurheartj/ehz425.
2. Pharmacology of Silymarin / F. Fraschini [et al.] // Clin. Drug Invest. — 2012. — Vol. 22, № 1. — P. 51–65.
3. Roffi M., Patrono C., Collet J.P., Mueller C., Valgimigli M., Andreotti F., et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267-315. doi: 10.1093/eurheartj/ehv320.
4. Shevchenko E.A. Such different hepatoprotectors // VetPharma. - 2015. - № 2 (24). -С. 28-31.
5. Bulanova E. Yu. Statin therapy: evidence, expert opinions, prospects [Text] / E. Bulanova // Leсhebnoe delo. - 2013. - № 3. - С. 59-77
6. Kabakova A.V., Galyavich A.S. The role of statins in therapy of patients with coronary heart disease [Text] / A.V. Kabakova, A.S. Galyavich // Advances in Modern Science and Education. - 2016. - Т. 3, № 9. - С. 157-162.
7. New possibilities of preventive therapy with statins in the rehabilitation of coronary heart disease patients with moderate clinical manifestations of chronic heart failure: effectiveness of rosuvastatin and ezetimibe [Text] / N.I. Tarasov, M.N. Sinkova, L.K. Isakov [et al. - 2016. - Т. 15, № 3. - С. 20-24.
8. Konovalov A.V. Hepatoprotectors of plant origin in the rearing of replacement heifers / A.V. Konovalov, Yu.J. Kravainis, R.S. Kravaine // Multifunctional adaptive fodder production: collection of scientific papers. - Moscow: Ugreshskaya typografia, 2017. - С. 123-129.
Published
2022-12-07
How to Cite
Tokhirovna, B. N., Otakhanovich, Z. O., & Fayzullaevna, M. G. (2022). Effect of Combined Therapy of Atorvastatin with Milk Thistle Extract on the Functional State of the Liver in Patients with CHD. Central Asian Journal of Medical and Natural Science, 3(6), 301-304. https://doi.org/10.17605/cajmns.v3i6.1208
Section
Articles